Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02037 |
| Species: | Homo sapiens |
| Position : | chr5:131406243-131406930 |
| Year: | 2004 |
| Title: | Granulocyte-macrophage colony-stimulating factor enhancer activation requires cooperation between NFAT and AP-1 elements and is associated with extensive nucleosome reorganization. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 15340054 |
| Tissue: | blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | Jurkat |
| CVCL ID: | CVCL_0065 |
| Cell Type: | T cell |
| Cell Ontology ID: | CL:0000084 |
| Experiment Type: | Enhancer activity assay; TF binding assay; Functional perturbation assay; Chromatin accessibility assay; Chromatin remodeling assay; In vivo functional validation |
| Low Throughput Method: | Site-directed mutagenesis; transient transfection; luciferase reporter assay; PMA/A23187 stimulation; antibody-EMSA; DMS in vivo footprinting; LM-PCR; DNase I hypersensitivity assay; DNase I footprinting; MNase nucleosome mapping; restriction enzyme accessibility assay; In vivo phenotyping |
| Target gene : | CSF2 |
| TF name : | NFATC1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| NFATC1 | AP-1 transcription factor network | pid | 71 |
| NFATC1 | BCR signaling pathway | pid | 70 |
| NFATC1 | Ca2+ pathway | reactome | 62 |
| NFATC1 | Calcineurin-regulated NFAT-dependent transcription in lymphocytes | pid | 50 |
| NFATC1 | Calcium signaling in the CD4+ TCR pathway | pid | 29 |
| NFATC1 | CLEC7A (Dectin-1) induces NFAT activation | reactome | 13 |
| NFATC1 | Downstream signaling in naïve CD8+ T cells | pid | 69 |
| NFATC1 | FCERI mediated Ca+2 mobilization | reactome | 41 |
| NFATC1 | Glucocorticoid receptor regulatory network | pid | 85 |
| NFATC1 | Inflammation mediated by chemokine and cytokine signaling pathway | panther | 189 |
| NFATC1 | RANKL | netpath | 84 |
| NFATC1 | Role of Calcineurin-dependent NFAT signaling in lymphocytes | pid | 54 |
| NFATC1 | Signaling by Wnt | reactome | 10 |
| NFATC1 | TCR | netpath | 261 |
| NFATC1 | Validated transcriptional targets of AP1 family members Fra1 and Fra2 | pid | 37 |
| NFATC1 | Wnt signaling pathway | panther | 250 |
| NFATC1 | Wnt signaling pathway | kegg | 135 |
| NFATC1 | Axon guidance | kegg | 126 |
| NFATC1 | VEGF signaling pathway | kegg | 70 |
| NFATC1 | Natural killer cell mediated cytotoxicity | kegg | 125 |
| NFATC1 | T cell receptor signaling pathway | kegg | 105 |
| NFATC1 | B cell receptor signaling pathway | kegg | 70 |
| NFATC1 | Hs_VEGFA-VEGFR2_Signaling_Pathway_WP3888_90000 | wikipathways | 153 |
| NFATC1 | Hs_TLR4_Signaling_and_Tolerance_WP3851_90114 | wikipathways | 8 |
| NFATC1 | Hs_T-Cell_antigen_Receptor_(TCR)_Signaling_Pathway_WP69_89937 | wikipathways | 60 |
| NFATC1 | Hs_RANKL-RANK_(Receptor_activator_of_NFKB_(ligand))_Signaling_Pathway_WP2018_90016 | wikipathways | 26 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_02035 | chr5:131406243-131406930 | blood | T cell | NA |
| E_02036 | chr5:131406243-131406930 | blood | T cell | NA |
| E_02038 | chr5:131406243-131406930 | blood | T cell | NA |
| E_03687 | chr5:131406243-131406930 | blood | T cell | NA |
| E_03688 | chr5:131406243-131406930 | blood | T cell | NA |
| E_04044 | chr5:131406243-131406930 | blood | T cell | NA |
| E_04598 | chr5:131406243-131406930 | blood | T cell | NA |
| E_04599 | chr5:131406243-131406930 | blood | T cell | NA |